WuXi AppTec removed from Pentagon Chinese military companies list
WuXi AppTec was removed from the Pentagon’s list of Chinese military companies after a federal court enjoined the department from enforcing the designation, according to a government posting.
By Hermes-Vector AI Desk
Checked against 2 sourcescentraloregondaily.comsrnnews.com
In brief
- WuXi AppTec was removed from the Pentagon’s list of Chinese military companies on November 9, 2026.
- The deputy secretary of defense made the determination after a federal court enjoined enforcement of the designation.
- WuXi AppTec sued, calling its designation arbitrary, capricious, unsupported by the facts and 'the product of political pressure.'
- The Pentagon expanded its blacklist of alleged Chinese military companies to 188 entities on June 8.
Removal from Pentagon list
Chinese biotechnology company WuXi AppTec was removed from the Pentagon’s list of Chinese military companies, according to a government posting on Monday, November 9, 2026. The deputy secretary of defense made the determination in light of a federal court in Washington enjoining the department from enforcing the designation, the posting said.
Lawsuit and court ruling
The ruling came in a lawsuit WuXi AppTec filed after it was added to the list. In that lawsuit, WuXi AppTec said its designation was arbitrary, capricious, unsupported by the facts and "the product of political pressure."
Pentagon list background
The Pentagon expanded its blacklist of alleged "Chinese military companies" on June 8 to 188 entities.
Why it matters
The removal means WuXi AppTec is no longer subject to enforcement of the Pentagon’s Chinese military company designation. The company remains a Chinese biotechnology company, and the list remains in effect for other entities.
Sources
- centraloregondaily.com: Wuxi Apptec removed from Pentagon list of chinese military companies | Consumer | centraloregondaily.com
- srnnews.com: Wuxi Apptec removed from Pentagon list of chinese military companies - SRN News
This article was drafted with AI assistance and checked against the sources above. Company claims are reported as claims. Cover image is AI-generated.
The day's checked news, by email
One short email a day with the top stories. Free, and you can unsubscribe in one click.
Or follow for the latest news:
Advertisement
How do you feel about this story?
Comments 0
No comments yet. Start the discussion.
More Health stories
FDA Orders New Warning on GLP-1 Drugs Over Rare Eye Condition
The FDA is requiring GLP-1 drugmakers to add a warning label about NAION, a rare eye condition that can cause sudden, permanent vision loss.
Checked against 5 sourcesNBC Newsnypost.comtwaslnews1.twaslnews.com+2 more
HealthTrending
B.C. Tribunal Orders LifeLabs to Pay $32,000 for Misgendering Patients
A British Columbia tribunal ordered LifeLabs to pay $32,000 to three transgender and non-binary patients after staff misgendered them or disclosed their transgender status during lab visits in 2019.
Checked against 2 sourcesgayety.comcanadianinquirer.net